- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Sensory Neglect in Belgium
Total 16 results
-
University GhentFund for Scientific Research, Flanders, BelgiumCompletedSpatial Neglect After StrokeBelgium
-
Universiteit AntwerpenUnknownStroke | Cerebrovascular Disorders | Sensory DisorderBelgium
-
Vrije Universiteit BrusselActive, not recruitingStroke | NeglectBelgium
-
Vrije Universiteit BrusselCompletedLow Back Pain | Central Sensitisation | Sensory Profiles | Nociplastic PainBelgium
-
KU LeuvenTerminated
-
Universiteit AntwerpenCompletedStroke | Spatial Neglect | Postural ControlBelgium
-
Universitaire Ziekenhuizen KU LeuvenUniversiteit AntwerpenRecruitingBreast Cancer | Lymphedema | Sensory Processing DisorderBelgium
-
Ziekenhuis Oost-LimburgNot yet recruitingArthroplasty Complications | Tensor Fasciae Latae SyndromeBelgium
-
Hasselt UniversityJessa Hospital; Revalidatie & MS Centrum OverpeltCompletedStroke | Multiple Sclerosis | Neurological Diseases or Conditions | Sensory DisordersBelgium
-
Vrije Universiteit BrusselJessa Hospital; Universitair Ziekenhuis Brussel; Erasmus University Rotterdam; Odisee... and other collaboratorsCompletedStroke | Covid19 | Parkinson Disease | Neglect, HemispatialBelgium
-
Centre Hospitalier Universitaire Saint PierreUniversité Libre de BruxellesWithdrawnNerve Entrapment Syndrome | Cluneal SyndromeBelgium
-
Pharnext S.C.A.Premier Research Group plc; Eurofins Optimed; Synteract HCR (Syneos Health); Gr... and other collaboratorsActive, not recruitingCharcot-Marie-Tooth Disease, Type IAUnited States, Belgium, Canada, France, Netherlands, Spain, United Kingdom
-
Immunocore LtdRecruitingSelect Advanced Solid TumorsUnited States, Belgium, Korea, Republic of, Australia, Germany, United Kingdom, Spain, Poland, Austria, Brazil, Canada, New Zealand, France, Italy, Netherlands, Switzerland
-
Pharnext S.C.A.Worldwide Clinical TrialsActive, not recruitingCharcot-Marie-Tooth DiseaseUnited States, Spain, Belgium, Italy, Israel, Canada, Denmark, France, Germany
-
Pharnext SACompletedPhase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT) (PLEO-CMT)Charcot-Marie-Tooth Disease Type 1AUnited States, United Kingdom, Belgium, Canada, France, Netherlands, Spain, Germany
-
Centre Hospitalier Universitaire de LiegeSanofi; Takeda; University of Liege; Orchard Therapeutics; Centre Hospitalier Régional... and other collaboratorsRecruitingCongenital Adrenal Hyperplasia | Hemophilia A | Hemophilia B | Mucopolysaccharidosis I | Mucopolysaccharidosis II | Cystic Fibrosis | Alpha 1-Antitrypsin Deficiency | Sickle Cell Disease | Fanconi Anemia | Chronic Granulomatous Disease | Wilson Disease | Severe Congenital Neutropenia | Ornithine Transcarbamylase... and other conditionsBelgium